MARSHALL WACE, LLP - PLURISTEM THERAPEUTICS INC ownership

PLURISTEM THERAPEUTICS INC's ticker is PSTI and the CUSIP is 72940R102. A total of 36 filers reported holding PLURISTEM THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 1.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of PLURISTEM THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$060.00%
Other shareholders
PLURISTEM THERAPEUTICS INC shareholders Q1 2019
NameSharesValueWeighting ↓
ARK Investment Management 3,793,249$3,679,0000.10%
Nikko Asset Management Americas, Inc. 928,240$900,0000.02%
ETF MANAGERS GROUP, LLC 243,009$233,0000.01%
Virtu Financial LLC 85,104$83,0000.01%
Psagot Value Holdings Ltd. 127,215$123,0000.01%
HERITAGE INVESTORS MANAGEMENT CORP 74,878$73,0000.00%
Harel Insurance Investments & Financial Services Ltd. 33,794$33,0000.00%
Certified Advisory Corp 5,000$5,0000.00%
Sumitomo Mitsui Trust Holdings, Inc. 908,095$881,0000.00%
Renaissance Technologies 1,580,610$1,533,0000.00%
View complete list of PLURISTEM THERAPEUTICS INC shareholders